ANALYTICAL METHODS · PRACTICAL GUIDE
Peptide Lot Documents: Connect the Quote, Vials and Reports
Build a record that connects what was agreed with what arrived.
You receive several vials and a folder of PDF files. Which report belongs to which material? A useful batch record connects an order, a material lot and the actual delivered units. A large folder is not useful if those links cannot be followed.
1. Start with an identity chain
Use a fictional order PO-DEMO-01, material lot LOT-DEMO-A, report R-DEMO-07 and vial labels carrying LOT-DEMO-A. The strings do not have to be identical across every document, but their relationship must be clear.
If the laboratory uses a separate sample number, request a documented mapping to the material lot. Do not silently decide that similar-looking dates or filenames establish the link.
2. Separate requirements from available evidence
Before ordering, make a small table of what the experiment needs and what the supplier has actually confirmed. The word “required” in your request does not mean the test exists. Likewise, a generic website description does not confirm a batch result.
| Planned requirement | Ask before ordering | Check on receipt |
|---|---|---|
| Exact material form | Which variant will be supplied? | Label and agreed specification |
| Quantity | Gross or content-adjusted basis? | Delivered quantity and basis |
| Identity and purity records | Which lot-specific items are available? | Lot mapping and results |
| Storage information | Applicable product instructions? | Documents supplied for the material |
Use “confirmed,” “not available” and “to be agreed” deliberately. Those entries help prevent a sales discussion from becoming an assumed technical commitment.
3. Check delivered quantities without inventing per-vial guarantees
In a teaching example, ten vials are labeled 1 mg each and the order says 10 mg total. Those statements are arithmetically consistent. They do not alone prove that each vial was independently weighed or tested.
Ask what the quantity claim means and how filling was controlled if vial-level amounts are important. A test on one sample should not be silently extended to every vial without a suitable sampling rationale.
4. Record discrepancies before using the material
Suppose the vial says LOT-DEMO-A but the report says LOT-DEMO-B, with no mapping. This is a traceability question. Preserve both records and ask the supplier to resolve it; do not edit the PDF or infer which number is correct.
Other useful discrepancy notes include a different terminal modification, an unexplained salt change or a result with no reporting basis. Describe the specific conflict rather than saying only that the documents look wrong.
5. A new lot is a new record
A report for a previous order is not evidence for a new batch. Compare exact forms, methods and measurement bases before attributing a changed assay result to the peptide itself. Also keep your own preparation and storage records: procurement documents cannot describe everything that happens after receipt.
Check your answer
Ask for the report associated with the delivered lot or a documented mapping. Do not relabel the old report as evidence for the new material.
6. Keep a simple receipt checklist
Save the agreed specification, quantity basis, order-to-lot link, vial labels, available reports and outstanding questions together. Record the date and any corrected document version. FDA’s analytical-method guidance emphasizes usable analytical documentation in a drug-development context; it is not a certification of a research supplier. Your record should be proportionate to the actual laboratory question.
Use this guide in a product enquiry
For materials such as MOTS-c、LL-37, identify the exact form, quantity and research question first. Then ask what records are available for the relevant lot. Matching product names do not make different specifications interchangeable.
Discuss products and document requirements with NHD. Continue learning: Reading a COA / Purity versus content.